Figure 1.
CD8+ T-cell subsets in controls and patients with B-CLL. Representative dot plot of a 3-color immunostaining of CD8+ T-cell subsets in a healthy control (left) and a patient with Rai stage 0 B-CLL (right). Cells were gated on lymphogate via forward/side scatter (FSC/SSC) and subsequently on CD8-PercP after which the following subsets can be distinguished based on CD45RA-PE and CD27-FITC: CD45RA+CD27- cytotoxic effector cells, CD45RA+CD27+ naive cells, and CD45RA-CD27+ noncytotoxic cells.

CD8+ T-cell subsets in controls and patients with B-CLL. Representative dot plot of a 3-color immunostaining of CD8+ T-cell subsets in a healthy control (left) and a patient with Rai stage 0 B-CLL (right). Cells were gated on lymphogate via forward/side scatter (FSC/SSC) and subsequently on CD8-PercP after which the following subsets can be distinguished based on CD45RA-PE and CD27-FITC: CD45RA+CD27- cytotoxic effector cells, CD45RA+CD27+ naive cells, and CD45RA-CD27+ noncytotoxic cells.

Close Modal

or Create an Account

Close Modal
Close Modal